Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)

Clinical trial NCT05457790 · SUSPENDED

Trial details

NCT number: NCT05457790
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anemia Insomnia Sleeplessness Transient Insomnia Nonorganic Insomnia Chronic Insomnia

Start date: 2024-05-03
Primary completion: 2026-10-31
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.